-

Komodo Health Announces Renewal of CMS Qualified Entity Certification

Komodo Health has been certified under the CMS “Qualified Entity” program since 2017

SAN FRANCISCO & NEW YORK--(BUSINESS WIRE)--Komodo Health today announced it has renewed its certification in the Centers for Medicare and Medicaid Services (CMS) Qualified Entity (QE) Program, also known as the Medicare Data Sharing for Performance Measurement Program. Komodo Health has been a certified QE since August 2017, enabling the company to offer the most complete view of 320 million patient journeys across the U.S. healthcare system.

As a QE, Komodo Health is entrusted with claims data under Medicare Parts A, B, and D for use in evaluating the performance of healthcare providers in the U.S. health system. During its tenure in the CMS Qualified Entity Program, Komodo has been systematically evaluating health system performance, access to care, and effectiveness in healthcare delivery across the entire payer landscape.

“Despite an onslaught of data in healthcare today, there is a surprising absence of insights that healthcare stakeholders can act on with confidence,” said Arif Nathoo, MD, CEO of Komodo Health. “We believe that healthcare needs a source of ground truth to close gaps in care delivery. Our ability to capture a more complete view of patient journeys enables Komodo Health to address disease burden through a richer understanding of public health.”

As part of its QE status, Komodo Health is held to a rigorous standard for data privacy and security. Komodo’s QE status is renewed for an additional three years, until August 2023.

Komodo’s Healthcare Map™ captures insights on 320 million patient journeys, including 15 million daily clinical encounters from hundreds of sources. This comprehensive view of de-identified patient encounters enables its customers to model the epidemiology of disease and direct resources where they are needed most. On that foundation, Komodo has developed innovative software solutions that use AI to pinpoint geographic “hot spots” for disease, and drive insights to improve quality and outcomes for patients.

About Komodo Health

Komodo Health believes that smarter, more innovative use of data and analytics is essential for reducing disease burden. We apply artificial intelligence and other advanced data science techniques to our first-of-its-kind Healthcare Map™, which tracks the unique patient journeys of over 320 million patients. We empower a multitude of healthcare stakeholders — life science companies, healthcare payers and providers, patient advocacy groups, and others — to create a more cost-effective, value-driven healthcare system. For more information, visit komodohealth.com.

Contacts

Media:
Christine Douglass
Director of Communications, Komodo Health
christine.douglass@komodohealth.com

Komodo Health


Release Versions

Contacts

Media:
Christine Douglass
Director of Communications, Komodo Health
christine.douglass@komodohealth.com

Social Media Profiles
More News From Komodo Health

Komodo Health Appoints Mark Jewett to Chief Marketing Officer

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--Komodo Health, the leader in AI-powered healthcare intelligence, today announced the appointment of Mark Jewett as Chief Marketing Officer (CMO). Jewett will lead the company’s marketing, shaping brand, communications, and go-to-market strategy as it scales Marmot™ — its new AI platform designed to help Life Sciences and healthcare organizations innovate faster and serve patients better. The appointment comes following a period of significant momentum...

Komodo Health Analysis Uncovers Dual Reality in Metastatic Breast Cancer Care: Rapid Targeted Cancer Therapy Adoption Amid Glaring Age-Related Disparities

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--On the 40th anniversary of Breast Cancer Awareness Month, a new analysis from Komodo Health, the leader in AI-powered healthcare intelligence, conducted in collaboration with the Tigerlily Foundation, a national breast cancer patient advocacy organization, delivers critical insights into antibody-drug conjugate (ADC) treatment patterns in metastatic breast cancer. The study confirms growing clinical acceptance of this innovative therapy but also reveal...

Komodo Health Recognized by Forbes, TIME, and The Healthcare Technology Report for Healthcare Analytics AI Innovation

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--Komodo Health, the leader in AI-powered healthcare intelligence, today announced that it has earned recognition on three prestigious industry lists: the 2025 Forbes Cloud 100, TIME’s inaugural World’s Top HealthTech Companies, and The Healthcare Technology Report’s Top 25 Healthcare Software Companies. These honors validate Komodo’s differentiated approach to healthcare analytics AI — purpose-built from the ground up rather than retrofitted from consum...
Back to Newsroom